Theranostics in Prostate Cancer.

Serum Thioredoxin as a Diagnostic Marker for Hepatocellular Carcinoma in Cirrhotic Hepatitis C Patients

Serum and Urinary Prostatic Cancer Antigen 3 as Diagnostic Biomarkers for Prostate Cancer

Proline Dehydrogenase As An Indication for Treatment Response in Sera of Patients With Breast Cancer

Role of miRNA-182 and 187 as Diagnostic and Prognostic Biomarkers for Prostate Cancer

Evaluation the diagnostic and prognostic value of PCA3, PSA, IL-6 and TNF-α in prostate cancer and benign prostate hyperplasia

Evaluation of cell free circulating plasma DNA in prostate cancer

The value of various prostate cancer tumor markers in early detection, diagnosis, follow up and monitoring of the treatment

The role of multi-parametric magnetic resonant imaging as a non invasive biomarker for differentiation between different prostatic lesions

Evaluation of Serum Level of Thioredoxin and its Gene Polymorphism in Diagnosis of Hepatocellular Carcinoma of HCV-Infected Patients